Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Jazz Pharma to Sell Women’s Health Business

By Pharmaceutical Processing | September 6, 2012

NEW YORK (AP) — The Irish drugmaker Jazz Pharmaceuticals PLC is selling its women’s health business to specialty pharmaceutical company Meda for $95 million in cash so that it can concentrate on its core products.

Jazz, which combined with Azur Pharma in January and relocated to Ireland, said Thursday that the sale includes the estradiol gel Elestrin, the menopause symptom treatment Gastrocrom, prenatal vitamin Natelle One, AVC Cream, prenatal multivitamin Gesticare DHA and urinary antiseptic Urelle. Sales of the products totaled $30.4 million last year.

Meda said that it views Elestrin as the most important product in the deal as it is one of the leading brands in the estrogen replacement therapy market and will add to its existing sales.

Jazz said that as part of the sale Meda will offer jobs to about 60 Jazz employees that directly support these products.

Meda says that it will finance the transaction with existing credit facilities.

The sale does not need the approval of Jazz shareholders but is subject to antitrust clearance.

The deal is expected to close in the fourth quarter. Jazz expects a one-time gain on the sale during that quarter.

U.S. shares of Jazz closed at $44.93 on Wednesday. They are down 17.6 percent from their 52-week high of $54.50 in late April.

 

 

Related Articles Read More >

A Zipline fixed-wing drone in the air drops a package
Cardinal Health starts Zipline drone deliveries of drugs and medical supplies
Pfizer logo
Pfizer to spend $120M to make COVID-19 oral treatment in U.S.
Image of MedTrace Pharma's P3 automated delivery system for 15-O water in action
MedTrace Pharma moves forward on 15 O-water imaging tech
coronavirus COVID-19 Pfizer
NIH starts evaluating second COVID-19 booster shots in adults

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards